NEW YORK (GenomeWeb News) — TechniKrom will supply its large-scale oligosynthesis equipment to South Korea-based Samchully Pharm, which is currently expanding its manufacturing facility in that country, the companies said today.
 
Under the agreement, TechniKrom, based in Evanston, Ill., will provide Samchully with its engineering, fabrication, and qualification services to supply 100-mmol scale cGMP oligosynthesis and HPLC equipment.
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.

Oct
17
Sponsored by
Lexogen

This webinar will present a method for RNA-seq expression analysis of FFPE-derived RNA samples that are too degraded for successful application of standard RNA-seq techniques.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.